title: The protective effect of supplemental calcium on colonic permeability depends on a calcium phosphate-induced increase in luminal buffering capacity.
abstract: An increased intestinal permeability is associated with several diseases. Previously, we have shown that dietary Ca decreases colonic permeability in rats. This might be explained by a calcium-phosphate-induced increase in luminal buffering capacity, which protects against an acidic pH due to microbial fermentation. Therefore, we investigated whether dietary phosphate is a co-player in the effect of Ca on permeability. Rats were fed a humanised low-Ca diet, or a similar diet supplemented with Ca and containing either high, medium or low phosphate concentrations. Chromium-EDTA was added as an inert dietary intestinal permeability marker. After dietary adaptation, short-chain fructo-oligosaccharides (scFOS) were added to all diets to stimulate fermentation, acidify the colonic contents and induce an increase in permeability. Dietary Ca prevented the scFOS-induced increase in intestinal permeability in rats fed medium- and high-phosphate diets but not in those fed the low-phosphate diet. This was associated with higher faecal water cytotoxicity and higher caecal lactate levels in the latter group. Moreover, food intake and body weight during scFOS supplementation were adversely affected by the low-phosphate diet. Importantly, luminal buffering capacity was higher in rats fed the medium- and high-phosphate diets compared with those fed the low-phosphate diet. The protective effect of dietary Ca on intestinal permeability is impaired if dietary phosphate is low. This is associated with a calcium phosphate-induced increase in luminal buffering capacity. Dragging phosphate into the colon and thereby increasing the colonic phosphate concentration is at least part of the mechanism behind the protective effect of Ca on intestinal permeability.
authors.affiliation: TI Food and Nutrition, PO Box 557, 6700 AN Wageningen, The Netherlands.
authors.forename: Marloes A A
authors.initials: MA
authors.lastname: Schepens
authors.forename: Sandra J M
authors.initials: SJ
authors.lastname: ten Bruggencate
authors.forename: Arjan J
authors.initials: AJ
authors.lastname: Schonewille
authors.forename: Robert-Jan M
authors.initials: RJ
authors.lastname: Brummer
authors.forename: Roelof
authors.initials: R
authors.lastname: van der Meer
authors.forename: Ingeborg M J
authors.initials: IM
authors.lastname: Bovee-Oudenhoven
mesh_terms: D000818:Animals; D002021:Buffers; D002130:Calcium Phosphates / Q000378:metabolism; D002136:Calcium, Dietary / Q000008:administration & dosage*; D002432:Cecum / Q000187:drug effects / Q000378:metabolism; D003106:Colon / Q000187:drug effects* / Q000502:physiology*; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000378:metabolism; D005285:Fermentation; D019344:Lactic Acid / Q000378:metabolism; D008297:Male; D009844:Oligosaccharides / Q000008:administration & dosage / Q000378:metabolism; D010539:Permeability / Q000187:drug effects; D010710:Phosphates / Q000008:administration & dosage / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D002021:Buffers; D002130:Calcium Phosphates; D002136:Calcium, Dietary; D004040:Dietary Carbohydrates; D009844:Oligosaccharides; D010710:Phosphates; D019344:Lactic Acid; C020243:calcium phosphate